ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 25846 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 25846; 2) Community: the network communities that were significantly associated with the response to NSC 25846; 3) Molecule: the relationships between components within communities and NSC 25846; 4) MDR: the compounds that were significantly associated with the NSC 25846.

NSC Compound Enrichment Correlation
NSC 742037 Null 0.0407060322613561 -0.052771093
NSC 745455 Null 0.0407060322613561 0.66766629
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0407060322613561 0.35951984
NSC 750324 Null 0.0407060322613561 0.14919112
NSC 755443 Null 0.0407060322613561 0.38503013
NSC 107124 Camptothecin Derivative 0.0407060322613564 0.087951204
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0407060322613564 0.32673755
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0407060322613564 0.072642097
NSC 134725 K-33 0.0407060322613564 0.13608525
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0407060322613564 0.44343759
Total:74  Current:65    [First] [Prev] [Next] [Last]